Stay updated on Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no changes to study content or page functionality are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T11:55:01.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.1 on the page footer; this change does not affect study information or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T10:59:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The notice about government funding and NIH operating status at the top of the page was removed. This change does not affect the study data, results, or navigation on the page.
    Difference
    0.4%
    Check dated 2025-11-17T06:10:35.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The latest view shows the addition of Version 39 dated 2025-10-06 in the Record History, while the rest of the page layout remains unchanged. This change does not alter core trial details; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:44:29.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Updates add a new study status update with date stamping and contacts/locations, and remove an earlier date entry. Core page content related to study status and locations appears to be refreshed.
    Difference
    0.9%
    Check dated 2025-10-19T16:07:09.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page has updated its status messaging with a government-operating notice and added a new revision version and date, while removing the previous revision reference. Overall, the significant changes are an updated operating-status notice, a new date (2025-09-29) and a new version (v3.2.0) replacing the old revision (v3.1.0).
    Difference
    11%
    Check dated 2025-10-05T07:17:38.000Z thumbnail image

Stay in the know with updates to Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.